Claya review
Claya is a compounded GLP-1 telehealth platform advertising 'Starting at $149 a month' for semaglutide (same price at every dose, per its own copy) and 'Starting at $199 a month' for tirzepatide.
- Semaglutide
- $149/mo (all doses, compounded)
- Tirzepatide
- $199/mo (starting dose, compounded)
- Coverage
- Coverage not published
- Brand-name
- Compounded only
Semaglutide · modeled / year
$1,788
Tirzepatide · modeled / year
$2,388
Pricing verified August 2026
The Index scorecard
Claya scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- Semaglutide is explicitly 'same price regardless of dosage' at $149/mo, removing dose-tier guesswork
- LegitScript Certified, BBB Accredited, and HIPAA Compliant badges all displayed together
- '$100 off your first month' promo code (100CLAYA) published openly with no intake required to see it
- Possible named pharmacy partners with specific cities (RedRock Pharmacy, St. George UT; Healthware House, Florence KY) — more specific than most peers' generic language, though worth re-confirming on a fresh read
The tradeoffs
- The advertised $149/$199 rates are qualified elsewhere on the same page as available 'with select multi-month plans' — a shopper reading only the 'a month' headline could reasonably assume pure month-to-month billing when a prepay term may be required
- No state coverage list is published anywhere on the public site
- No medical director or individually named prescriber found
- Tirzepatide carries no explicit 'same price any dose' guarantee the way semaglutide's does, so its real cost at a therapeutic dose is unclear
The bottom line
Best for: Cost-first shoppers who want a same-price-any-dose semaglutide plan, for shoppers willing to consider a multi-month prepay to get the advertised rate. Claya is a compounded GLP-1 telehealth platform advertising 'Starting at $149 a month' for semaglutide (same price at every dose, per its own copy) and 'Starting at $199 a month' for tirzepatide.
Ranked #97 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Claya.
- #108Tell Her Doc— TellHerDoc is a women's-health-oriented telehealth platform offering compounded and brand-name semaglutide/tirzepatide, backed by four named physicians (with published NPI numbers), four named compounding pharmacies.69/100
- #109WeightRx— WeightRx is a telehealth provider publishing compounded semaglutide at $250/mo and compounded tirzepatide at $83/mo.69/100
- #110Prime Doctor RX— Publishes its whole ladder and honors its own asterisk — then bills every 28 days and labels every price per month.69/100
- #111Nolu— A broad compounded lineup — GLP-1, microdose stacks, and NAD+/sermorelin all on one account — undercut by a 4-week (not calendar-month) billing cycle and no named clinical staff.68/100
- #112OrderlyMeds— OrderlyMeds is a telehealth provider selling compounded semaglutide and tirzepatide with no membership fees or hidden costs.68/100
- #113Harper Meds— Harper Meds (operated by Nexus Health Solutions LLC) is a compounded GLP-1 telehealth program pricing semaglutide from $149/mo and tirzepatide from $196/mo, all-inclusive of doctor consultation, prescription and shipping.68/100
The 18 programs nearest this one
Pricing, states and verification reflect Claya's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Claya's site. Not medical advice; see our disclosure.